Toward the optimized assessment of clinical outcomes in studies of novel treatments for Alzheimer's disease.
Saved in:
| Title: | Toward the optimized assessment of clinical outcomes in studies of novel treatments for Alzheimer's disease. |
|---|---|
| Authors: | Lipton RB; The Saul R. Korey Department of Neurology, Albert Einstein College of Medicine, New York, NY, USA., Podger L; Patient Centered Outcomes, OPEN Health, London, UK., Stewart WF; Medcurio Inc, Oakland, CA, USA., Gomez-Ulloa D; Global HEOR, Grifols - Sant Cugat Del Vallès, Barcelona, Spain., Rodriguez WI; Global HEOR, Grifols SSNA - Research Triangle Park, NC, USA., Runken MC; Global HEOR, Grifols SSNA - Research Triangle Park, NC, USA., Barnes FB; Patient Centered Outcomes, OPEN Health, MD, USA., Serrano D; Patient Centered Outcomes, OPEN Health, MD, USA. |
| Source: | Expert review of neurotherapeutics [Expert Rev Neurother] 2022 Oct; Vol. 22 (10), pp. 863-873. Date of Electronic Publication: 2022 Nov 29. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Taylor & Francis Country of Publication: England NLM ID: 101129944 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1744-8360 (Electronic) Linking ISSN: 14737175 NLM ISO Abbreviation: Expert Rev Neurother Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 1744-8360 |
|---|---|
| DOI: | 10.1080/14737175.2022.2149324 |
